Tousignant Jennifer — SEC Form 4 filings
SEC reporting owner CIK 2010978. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-20.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-14 to 2026-08-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 16,484 shares, $418,990 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 10,000 shares @ $24.50 ($245,000) in Viridian Therapeutics, Inc.\DE, filed 2026-08-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE (VRDN) | Chief Legal Officer | 7 | — | 3 legs · 16,484 sh · $418,990 | 11 |
Form 4 filings — Tousignant Jennifer
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Sale (S): 4,212 @ $24.50 · Option exercise (M): 10,000 @ $14.41 · Sale (S): 10,000 @ $24.50 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4/A | Viridian Therapeutics, Inc.\DE (VRDN) | Tax withholding (F): 1,675 @ $30.19 | EDGAR |
| 2026-03-04 | 4/A | Viridian Therapeutics, Inc.\DE (VRDN) | Holdings only — no transactions reported | EDGAR |
| 2026-03-04 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Option exercise (M): 5,169 · Tax withholding (F): 1,724 @ $29.32 · Grant/award (A): 119,300 (derivative) @ $0 · Grant/award (A): 23,850 (derivative) @ $0 · Option exercise (M): 5,169 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Sale (S): 2,272 @ $31.16 | EDGAR |
| 2025-03-04 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 124,072 (derivative) @ $0 · Grant/award (A): 20,679 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 290,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2010978 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →